Lung cancer [NEW TOPIC PAGE]

Main|Search|PHGKB



From National Institutes of Health Web Sites

---

• Approval of Osimertinib and Necitumumab Increases Lung Cancer Treatment Options  
• Bringing Precision to Screening for Cancer  
• Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches  
• FDA Approves Alectinib for ALK-Positive Non-Small Cell Lung Cancer  
• Most cases of lung cancer are due to smoking; however, there are other risk factors including family history.  
• Noninvasive strategies for lung cancer testing  
  NIH Research Matters, March 7, 2017
• Targeted Photoimmunotherapy Approach for Cancer Moves Forward  
• Two-Drug Combination Approved for Lung Cancers with BRAF Mutations  
  NCI, July 18, 2017
• Using Gene Expression to Diagnose Lung Cancer More Accurately  
• With FDA Approval, Gefitinib Returns to U.S. Market for Some Patients with Lung Cancer